TAG:
cap
Regional Lab Systems Beginning To Emerge
By Robert Michel | From the Volume IV No. 7 – May 12, 1997 Issue
CEO SUMMARY: Regionalization of laboratory services is about to become a dominant industry trend. Four groups of players will drive this process and each needs to recruit hospital laboratories to participate in their regional model. This is the first generation of attempts to create finan…
New Hybrid Lab Systems Provide Peek At Future
By Robert Michel | From the Volume IV No. 7 – May 12, 1997 Issue
CEO SUMMARY: As the first generation of regional laboratory systems begin operation, the marketplace is about to separate winners from losers. Stakes are high for hospital laboratory administrators. If they choose to affiliate with the wrong model, the consequences can cause extended disr…
Public Laboratories Struggling To Maintain Competitive Ability
By Robert Michel | From the Volume IV No. 7 – May 12, 1997 Issue
WITH regional laboratory systems as the theme of this issue, it is appropriate to look at the three national laboratories. What does 1997 and 1998 hold in store for them? For the last three years, news was uniformly bad for virtually every public laboratory. Problems at Corning Clinical Labo…
AmeriPath Stock Offering Pulled By Underwriters
By Robert Michel | From the Volume IV No. 6 – April 21, 1997 Issue
CEO SUMMARY: Ameripath planned to go public in March. However, the stock market’s significant decline and further evaluation of the company’s business plan caused Wall Street underwriters to defer issuing the stock. Pathologists are curious as to whether AmeriPath’s “employee” b…
Success Seems Elusive To Pathology Innovators
By Robert Michel | From the Volume IV No. 6 – April 21, 1997 Issue
CEO SUMMARY: Attempts to organize pathology practice management companies encounter resistance and market impediments. Success requires an astute business plan and a sophisticated management team to convince pathologists to abandon proven practice models and affiliate with regional or nat…
Where’s The Write-down ? LabCorp Faces Key Decision
By Robert Michel | From the Volume IV No. 6 – April 21, 1997 Issue
CEO SUMMARY: Commercial laboratories are recognizing declines in the market value of their assets. LabCorp has yet to do the same. Taken cumulatively, these write-downs demonstrate the sizable revenue erosion that large commercial laboratories experienced during the past three years. Soon…
LabCorp Struggling To Regain Financial, Operational Balance
By Robert Michel | From the Volume IV No. 6 – April 21, 1997 Issue
CEO SUMMARY: 1997 will be a “make or break” year for Laboratory Corporation of America. The company is challenged on many fronts. As LabCorp’s management focuses on internal issues, nimble laboratory competitors have an opportunity to capture additional market share. …
Laboratory War College To Highlight Innovation
By Robert Michel | From the Volume IV No. 6 – April 21, 1997 Issue
CEO SUMMARY: Quickly establishing itself as the premiere event for the management of clinical laboratories, this year’s Executive War College in New Orleans offers specialized advice and experience for laboratory administrators. Expect to hear the first public presentations about innova…
Another Portent Of Change
By R. Lewis Dark | From the Volume IV No. 5 – March 31, 1997 Issue
How many laboratory executives and pathologists consider themselves futurists? Probably not many, because healthcare’s traditional fee-for-service arrangements provided little financial incentive to alter the status quo. Yet I would argue that the radical restructuring of healthcare currently unde…
Meditech & LabSoft Top 1996 LIS Sales Rankings
By Robert Michel | From the Volume IV No. 5 – March 31, 1997 Issue
CEO SUMMARY: Turnover and turmoil are the big news in the LIS field. Hospitals and commercial laboratories are upgrading or replacing their existing LIS software at a rapid pace. Meanwhile, mergers and consolidations within the LIS industry create new power players. LIS conversion project…
CURRENT ISSUE
Volume XXXIII, No. 4 – March 23, 2026
A federal court ruling has established a safe harbor for clinical labs when they run tests ordered by physicians. Lab leaders should examine this briefing for pitfalls. Also, it turns out that providers may be ordering inappropriate vitamin D tests, according to one expert.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized